Contact coating of prostheses

Details Contact coating of prostheses Contact coating of prostheses

2005-12-02

2008-03-18

Edwards, Laura (Department: 1792)

Coating apparatus

Solid applicator contacting work

Pads or absorbent or porous applicators

C118S260000, C118S268000

Reexamination Certificate

active

07344599

ABSTRACT:
A method an apparatus for coating prostheses via contact patterning with an applicator. Applicators can include rollers, tampons, and ribbons. Coating materials include a variety of substances including polymers and therapeutic agents.

REFERENCES:
patent: 5763330 (1998-06-01), Bertolucci et al.
patent: 5773081 (1998-06-01), Williamitis et al.
patent: 5925259 (1999-07-01), Biebuyck et al.
patent: 5931851 (1999-08-01), Morales
patent: 6352768 (2002-03-01), Hseih et al.
patent: 6413318 (2002-07-01), Yoo et al.
patent: 6428853 (2002-08-01), Eriksson
patent: 6971813 (2005-12-01), Shekalim et al.
patent: WO 02/14078 (2002-02-01), None
Adler, L.M., et al., “Analysis of exposure times and dose escalation of paclitaxel in ovarian cancer cell lines,” Cancer 74(7) :1891-1898, Abstract only, 1994.
“Basic Theory: How does transfer pad printing work?,” http://www.itwtranstech.com/pages/how.html, Trans Tech America Inc., 2002.
Farb, Andrew, “Comparitive Pathology of Drug Eluting Stents: Insights Into Effectiveness and Toxicity from the Animal Lab,” Presentation from CRF Drug-Eluting Stent Symposium, http://tctmd.com/expert-presentations, 2002.
Hiatt, Bonnie L. et all., “Drug-Eluting Stents for Prevention of Restenosis: In Quest for the Holy Grail” Catheterization and Cardiovascular Interventions 55:409:417, 2002.
Kalinowski, M., et al., “Paclitaxel inhibits proliferation of cell lines responsible for metal stent obstruction: Possible topical appliaiotn in malignant bile duct obstructions,” Invest Radiol 37(7):399-404, Abstract only, 2002.
Kandzari, David E., et al., “Highlights from the American Heart Association Annual Scientific Sessions 2001 : Nov. 11 to 14, 2001,” American Heart Journal 143(2) :217-228, 2002.
Liebmann, J.E., et al., “Cytotoxic studies of paclitaxel (Taxol) in human tumor cell lines,” Br J Cancer 68(6) :1104-1109, Abstract only, 1993.
Regar, E., et al., “Stent development and local drub delivery,” Br Med Bull 59:227-248, Abstract only, 2001.
Taxol Quanam Data and the SCORE Study, Grube E. (the effect of taxol on the edges of the stent and dose response screening) 6-7. ISET 2002 Miami Beach, Mar. 19-23, 2002.
Sirolimus: Pre-clinical studies—Evaluation of dosing, efficacy and toxicity. Andrew J. and Carter D.O., TCT Sep. 2001.

Affiliated with

Also associated with

Rating

Contact coating of prostheses does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Contact coating of prostheses, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Contact coating of prostheses will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3967537